Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
성장 중
회사는 성장 단계에 있으며, 최신 연간 수익은 미화 7.01M에 달합니다.
고수익 성장
회사의 순이익은 업계 선두를 달리고 있으며, 최근 연간 순이익은 미화 7.01M에 달합니다.
공정한 가치
회사의 최신 PE은 -0.17로, 최근 3년 기준 중간 백분위 범위에 속합니다.
기관 매수
최신 기관 보유 주식 수는 12.23M주이며, 전 분기 대비 42.03% 증가했습니다.
PRFDX가 보유
스타 투자자 PRFDX이(가) 이 주식 20.80K주를 보유하고 있습니다.